Trapezius Oxygenation and Cervical Function in Chronic Neck Pain

October 2, 2026 updated by: Başak KAVALCI KOL, Kirsehir Ahi Evran Universitesi

Association Between Trapezius Muscle Oxygenation and Cervical Function in Individuals With Chronic Neck Pain

The aim of this study is to investigate the relationship between trapezius muscle oxygenation and cervical range of motion, muscle strength, and disability in individuals with chronic neck pain.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Chronic neck pain is a common musculoskeletal condition associated with impaired cervical mobility, reduced muscle performance, and increased disability. Alterations in local muscle oxygenation and microcirculation, particularly in the trapezius muscle, may contribute to persistent symptoms and functional limitations. Near-infrared spectroscopy provides a non-invasive method for assessing muscle oxygenation and hemodynamic responses. This study aims to investigate the relationship between trapezius muscle oxygenation, cervical range of motion, muscle strength, and disability in individuals with chronic neck pain.

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Kırşehir, Turkey (Türkiye), 40100
        • Kırşehir Ahi Evran University.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults aged 18-65 years with chronic neck pain lasting for at least 12 weeks who meet the study eligibility criteria.

Description

Inclusion Criteria:

  • Aged 18-65 years.
  • Chronic neck pain lasting for at least 3 months.
  • Neck pain intensity of ≥3 on the Visual Analog Scale during activity.
  • Willingness to participate in the study.

Exclusion Criteria:

  • Motor deficit in the upper extremities.
  • History of cervical or upper-extremity surgery.
  • Rheumatologic or neurologic disease.
  • Any musculoskeletal condition affecting upper-extremity function.
  • Cervical injection or other invasive procedure within the previous 6 months.
  • Cognitive impairment preventing understanding or performance of study assessments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Chronic Neck Pain Group

Adults aged 18-65 years with chronic neck pain lasting at least 12 weeks will be included in the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trapezius Muscle Oxygen Saturation
Time Frame: First Day

Trapezius muscle oxygen saturation will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise.

First Day
Trapezius Total Hemoglobin
Time Frame: First day

Trapezius total hemoglobin will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise.

First day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trapezius Muscle Strength
Time Frame: Second Day

Upper and middle trapezius muscle strength will be measured using a handheld dynamometer.

Second Day
Cervical Range of Motion
Time Frame: Second day

Active cervical flexion, extension, lateral flexion, and rotation will be measured using a goniometer.

Second day
Neck Disability
Time Frame: Second day

Disability will be assessed using the Neck Disability Index (NDI; 0-50 points), with higher scores indicating greater disability.

Second day
Upper-Extremity Exercise Capacity
Time Frame: First Day

Maximum upper-extremity exercise capacity will be assessed using an arm ergometer test, with peak workload recorded in watts.

First Day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 5, 2026

Primary Completion (Estimated)

November 5, 2026

Study Completion (Estimated)

January 5, 2027

Study Registration Dates

First Submitted

September 28, 2026

First Submitted That Met QC Criteria

September 28, 2026

First Posted (Actual)

October 2, 2026

Study Record Updates

Last Update Posted (Actual)

October 6, 2026

Last Update Submitted That Met QC Criteria

October 2, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • AhiEvranU531

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.